B-Symptom	0	10	Peripheral
I-Symptom	11	18	Lesions
O	19	29	Identified
O	30	32	on
B-Diagnostic_tool	33	42	Ultrawide
I-Diagnostic_tool	43	48	Field
I-Diagnostic_tool	49	56	Imaging
O	57	64	Predict
O	65	74	Increased
O	75	79	Risk
O	80	82	of
B-Disease	83	91	Diabetic
I-Disease	92	103	Retinopathy
O	104	115	Progression
O	116	120	over
O	121	122	4
O	123	128	Years
O	128	129	.

O	131	133	To
O	134	143	determine
O	144	151	whether
B-Symptom	152	162	peripheral
I-Symptom	163	171	diabetic
I-Symptom	172	183	retinopathy
I-Symptom	184	185	(
I-Symptom	185	187	DR
I-Symptom	187	188	)
I-Symptom	189	196	lesions
O	197	207	identified
O	208	210	on
B-Diagnostic_tool	211	220	ultrawide
I-Diagnostic_tool	221	226	field
I-Diagnostic_tool	227	228	(
I-Diagnostic_tool	228	231	UWF
I-Diagnostic_tool	231	232	)
I-Diagnostic_tool	233	240	imaging
O	241	244	are
O	245	255	associated
O	256	260	with
O	261	270	increased
B-Disease	271	273	DR
O	274	285	progression
O	285	286	.

O	287	298	Prospective
O	298	299	,
O	300	312	longitudinal
O	313	319	cohort
O	319	320	.

O	321	324	Two
O	325	332	hundred
B-Anatomy	333	337	eyes
O	338	340	of
O	341	344	100
O	345	357	participants
O	358	368	previously
O	369	377	enrolled
O	378	380	in
O	381	382	a
O	383	394	comparative
O	395	405	instrument
O	406	416	validation
O	417	422	study
O	422	423	.

O	424	432	Baseline
O	433	442	mydriatic
O	443	444	7
O	444	445	-
O	445	453	standard
O	454	459	field
B-Diagnostic_tool	460	465	Early
I-Diagnostic_tool	466	475	Treatment
I-Diagnostic_tool	476	484	Diabetic
I-Diagnostic_tool	485	496	Retinopathy
I-Diagnostic_tool	497	502	Study
I-Diagnostic_tool	503	504	(
I-Diagnostic_tool	504	509	ETDRS
I-Diagnostic_tool	509	510	)
I-Diagnostic_tool	511	522	photographs
O	523	526	and
B-Diagnostic_tool	527	530	UWF
I-Diagnostic_tool	531	537	images
O	538	542	were
O	543	551	obtained
O	551	552	.

O	553	555	On
B-Diagnostic_tool	556	559	UWF
I-Diagnostic_tool	560	566	images
O	566	567	,
B-Symptom	568	570	DR
I-Symptom	571	578	lesions
O	579	583	with
O	584	585	a
O	586	593	greater
O	594	600	extent
O	601	608	outside
O	609	615	versus
O	616	622	inside
O	623	631	standard
O	632	637	ETDRS
O	638	644	fields
O	645	649	were
O	650	657	defined
O	658	660	as
B-Symptom	661	674	predominantly
I-Symptom	675	685	peripheral
I-Symptom	686	693	lesions
O	694	695	(
B-Symptom	695	699	PPLs
O	699	700	)
O	700	701	.

O	702	708	Follow
O	708	709	-
O	709	711	up
B-Diagnostic_tool	712	717	ETDRS
I-Diagnostic_tool	718	729	photographs
O	730	734	were
O	735	743	obtained
O	744	745	4
O	745	746	.
O	746	747	2
O	747	748	Â±
O	748	749	0
O	749	750	.
O	750	751	3
O	752	757	years
O	758	763	after
O	764	772	baseline
O	772	773	.

O	774	782	Baseline
O	783	786	and
O	787	793	follow
O	793	794	-
O	794	796	up
B-Disease	797	799	DR
O	800	808	severity
O	809	813	were
O	814	820	graded
O	821	825	from
B-Diagnostic_tool	826	831	ETDRS
I-Diagnostic_tool	832	843	photographs
O	843	844	.

O	845	850	Rates
O	851	853	of
O	854	855	2
O	855	856	-
O	856	860	step
O	861	863	or
O	864	868	more
O	869	880	progression
O	881	884	and
O	885	896	progression
O	897	899	to
B-Disease	900	913	proliferative
I-Disease	914	916	DR
O	917	918	(
B-Disease	918	921	PDR
O	921	922	)
O	923	925	in
B-Anatomy	926	930	eyes
O	931	935	with
B-Symptom	936	940	PPLs
O	941	949	compared
O	950	954	with
B-Anatomy	955	959	eyes
O	960	967	without
B-Symptom	968	972	PPLs
O	973	983	identified
O	984	986	on
B-Diagnostic_tool	987	990	UWF
I-Diagnostic_tool	991	998	imaging
O	999	1001	at
O	1002	1010	baseline
O	1010	1011	.

O	1012	1014	In
B-Anatomy	1015	1019	eyes
O	1020	1027	without
B-Disease	1028	1031	PDR
O	1032	1033	(
O	1033	1034	n
O	1035	1036	=
O	1037	1040	109
O	1040	1041	)
O	1042	1044	at
O	1045	1053	baseline
O	1053	1054	,
O	1055	1057	56
O	1058	1059	(
O	1059	1061	51
O	1061	1062	%
O	1062	1063	)
O	1064	1067	had
O	1068	1070	at
O	1071	1076	least
O	1077	1078	1
O	1079	1084	field
O	1085	1089	with
B-Symptom	1090	1094	PPLs
O	1095	1098	and
O	1099	1101	43
O	1102	1103	(
O	1103	1105	39
O	1105	1106	%
O	1106	1107	)
O	1108	1111	had
B-Disease	1112	1114	DR
O	1115	1126	progression
O	1126	1127	.

O	1128	1136	Compared
O	1137	1141	with
B-Anatomy	1142	1146	eyes
O	1147	1154	without
B-Symptom	1155	1159	PPLs
O	1159	1160	,
B-Anatomy	1161	1165	eyes
O	1166	1170	with
B-Symptom	1171	1175	PPLs
O	1176	1179	had
O	1180	1181	a
O	1182	1183	3
O	1183	1184	.
O	1184	1185	2
O	1185	1186	-
O	1186	1190	fold
O	1191	1200	increased
O	1201	1205	risk
O	1206	1208	of
O	1209	1210	2
O	1210	1211	-
O	1211	1215	step
O	1216	1218	or
O	1219	1223	more
B-Disease	1224	1226	DR
O	1227	1238	progression
O	1239	1240	(
O	1240	1241	6
O	1242	1243	[
O	1243	1245	11
O	1245	1246	%
O	1246	1247	]
O	1248	1250	vs
O	1250	1251	.
O	1252	1254	19
O	1255	1256	[
O	1256	1258	34
O	1258	1259	%
O	1259	1260	]
O	1261	1262	;
O	1263	1264	P
O	1265	1266	=
O	1267	1268	0
O	1268	1269	.
O	1269	1272	005
O	1272	1273	)
O	1274	1277	and
O	1278	1279	a
O	1280	1281	4
O	1281	1282	.
O	1282	1283	7
O	1283	1284	-
O	1284	1288	fold
O	1289	1298	increased
O	1299	1303	risk
O	1304	1307	for
O	1308	1319	progression
O	1320	1322	to
B-Disease	1323	1326	PDR
O	1327	1328	(
O	1328	1329	3
O	1330	1331	[
O	1331	1332	6
O	1332	1333	%
O	1333	1334	]
O	1335	1337	vs
O	1337	1338	.
O	1339	1341	14
O	1342	1343	[
O	1343	1345	25
O	1345	1346	%
O	1346	1347	]
O	1348	1349	;
O	1350	1351	P
O	1352	1353	=
O	1354	1355	0
O	1355	1356	.
O	1356	1359	005
O	1359	1360	)
O	1360	1361	.

O	1362	1367	These
O	1368	1376	findings
O	1377	1385	remained
O	1386	1399	statistically
O	1400	1411	significant
O	1412	1417	after
O	1418	1427	adjusting
O	1428	1431	for
B-Characteristic	1432	1438	gender
O	1438	1439	,
B-Characteristic	1440	1448	diabetes
I-Characteristic	1449	1453	type
O	1453	1454	,
B-Characteristic	1455	1463	diabetes
I-Characteristic	1464	1472	duration
O	1472	1473	,
B-Characteristic	1474	1484	hemoglobin
I-Characteristic	1485	1488	A1c
I-Characteristic	1489	1490	(
I-Characteristic	1490	1495	HbA1c
I-Characteristic	1495	1496	)
I-Characteristic	1497	1503	levels
O	1503	1504	,
O	1505	1508	and
B-Characteristic	1509	1517	baseline
I-Characteristic	1518	1520	DR
I-Characteristic	1521	1529	severity
O	1529	1530	.

O	1531	1541	Increasing
O	1542	1548	extent
O	1549	1551	of
O	1552	1558	fields
O	1559	1563	with
B-Symptom	1564	1568	PPLs
O	1569	1578	increased
O	1579	1582	the
O	1583	1587	risk
O	1588	1591	for
O	1592	1593	2
O	1593	1594	-
O	1594	1598	step
O	1599	1601	or
O	1602	1606	more
B-Disease	1607	1609	DR
O	1610	1621	progression
O	1622	1623	(
O	1623	1624	P
O	1625	1626	=
O	1627	1628	0
O	1628	1629	.
O	1629	1632	004
O	1632	1633	)
O	1634	1637	and
O	1638	1649	progression
O	1650	1652	to
B-Disease	1653	1656	PDR
O	1657	1658	(
O	1658	1659	P
O	1660	1661	=
O	1662	1663	0
O	1663	1664	.
O	1664	1667	009
O	1667	1668	)
O	1668	1669	.

O	1670	1678	Presence
O	1679	1682	and
O	1683	1693	increasing
O	1694	1700	extent
O	1701	1703	of
B-Symptom	1704	1708	PPLs
O	1709	1713	were
O	1714	1724	associated
O	1725	1729	with
O	1730	1739	increased
O	1740	1744	risk
O	1745	1747	of
B-Disease	1748	1750	DR
O	1751	1762	progression
O	1763	1767	over
O	1768	1769	4
O	1770	1775	years
O	1775	1776	,
O	1777	1788	independent
O	1789	1791	of
O	1792	1800	baseline
B-Disease	1801	1803	DR
O	1804	1812	severity
O	1813	1816	and
B-Characteristic	1817	1822	HbA1c
I-Characteristic	1823	1829	levels
O	1829	1830	.

O	1831	1841	Increasing
O	1842	1848	extent
O	1849	1851	of
B-Symptom	1852	1856	PPLs
O	1857	1870	substantially
O	1871	1880	increased
O	1881	1884	the
O	1885	1889	risk
O	1890	1892	of
B-Disease	1893	1895	DR
O	1896	1907	progression
O	1908	1911	and
O	1912	1923	progression
O	1924	1926	to
B-Disease	1927	1930	PDR
O	1930	1931	,
O	1932	1942	especially
O	1943	1947	with
O	1948	1952	less
O	1953	1959	severe
B-Disease	1960	1962	DR
O	1963	1965	at
O	1966	1974	baseline
O	1974	1975	.

O	1976	1981	These
O	1982	1990	findings
O	1991	2002	demonstrate
O	2003	2007	that
O	2008	2016	detailed
B-Diagnostic_tool	2017	2027	peripheral
I-Diagnostic_tool	2028	2035	retinal
I-Diagnostic_tool	2036	2046	evaluation
O	2047	2055	provides
O	2056	2065	important
O	2066	2077	information
O	2078	2082	that
O	2083	2085	is
O	2086	2095	necessary
O	2096	2098	to
O	2099	2105	assess
O	2106	2116	completely
O	2117	2120	the
O	2121	2125	risk
O	2126	2128	of
B-Disease	2129	2131	DR
O	2132	2143	progression
O	2143	2144	.
